|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Newcastle Helix,Newcastle Upon Tyne,Tyne,GB
|
|
Iksuda Therapeutics is creating next-generation, class leading Antibody-Drug Conjugates (ADCs).
Our ADCs target difficult-to-treat cancers, including those that are resistant or refractory to current therapies.
We are building a pipeline of ADCs centred on:
• PermaLink® – proprietary conjugation chemistry for improved ADC stability
• Novel ultra-potent toxins for improved tumour killing
• Novel antibodies targeted towards well-selected antigens associated
primarily with solid tumours
We are focused on providing more effective treatments for patients who have few options, with a particular focus on solid tumours such as lung, ovarian, cervix, pancreatic and colorectal.
Our first wave ADC programmes include antibodies with proven premise in ADC formats and novel DNA damaging payloads.
We are working with leading research institutions in the US and Europe to develop exciting new therapies for the future. We are flexible in our approach to collaboration and welcome discussions with research groups who have novel ADC-relevant programmes.
We have developed a series of high-value ADC assets, which are available for collaborative research and license.
|
Iksuda Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Iksuda Therapeutics email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Iksuda Therapeutics customer service number call here +44(0)191 6031680. To contact Iksuda Therapeutics customer service number in your country click here to find.
David Simpson is the CEO of Iksuda Therapeutics. To contact David Simpson email at [email protected], [email protected] or [email protected]. Or you may call +44 (0) 7910166760
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.